Caldwell Trust CO Abb Vie Inc. Transaction History

Caldwell Trust CO

$1.07 Trillion
Q3 2025

A detailed history of Caldwell Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Caldwell Trust CO holds 24,989 shares of ABBV stock, worth $5.47 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

24,989

Previous 25,110 0.48%

Holding current value

$5.47 Million

Previous $4.66 Billion 24.14%

% of portfolio

0.54%

Previous 0.47%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$184.85 - $231.54 $22,366 - $28,016	-121 Reduced 0.48%	24,989 $5.79 Billion
Q2 2025 Sep 22, 2025	BUY	$170.16 - $206.27 $4.27 Million - $5.18 Million	25,110 New	25,110 $4.66 Billion
Q1 2025 Sep 23, 2025	SELL	$169.2 - $216.66 $128,422 - $164,444	-759 Reduced 3.02%	24,351 $5.1 Billion
Q4 2024 Sep 24, 2025	SELL	$164.99 - $203.87 $223,726 - $276,447	-1,356 Reduced 5.33%	24,107 $4.28 Billion
Q3 2024 Sep 24, 2025	BUY	$163.84 - $199.33 $88,145 - $107,239	538 Added 2.16%	25,463 $5.03 Billion
Q2 2024 Sep 24, 2025	SELL	$154.79 - $180.76 $75,382 - $88,030	-487 Reduced 1.92%	24,925 $4.28 Billion
Q1 2024 Sep 24, 2025	BUY	$159.82 - $182.1 $48,265 - $54,994	302 Added 1.2%	25,412 $4.63 Billion
Q4 2023 Oct 01, 2025	SELL	$137.6 - $154.97 $417,340 - $470,024	-3,033 Reduced 10.54%	25,746 $3.99 Billion
Q3 2023 Oct 01, 2025	SELL	$133.59 - $154.65 $360,559 - $417,400	-2,699 Reduced 8.57%	28,779 $4.29 Billion
Q2 2023 Oct 01, 2025	BUY	$132.51 - $164.9 $19,213 - $23,910	145 Added 0.46%	31,478 $4.24 Billion
Q1 2023 Oct 01, 2025	BUY	$144.61 - $166.54 $899,908 - $1.04 Million	6,223 Added 24.78%	31,333 $4.99 Billion
Q4 2022 Oct 01, 2025	SELL	$138.31 - $165.87 $273,162 - $327,593	-1,975 Reduced 5.9%	31,503 $5.09 Billion
Q3 2022 Oct 01, 2025	BUY	$134.21 - $153.93 $1.12 Million - $1.29 Million	8,368 Added 33.33%	33,478 $4.49 Billion
Q2 2022 Oct 01, 2025	SELL	$137.62 - $174.96 $38,258 - $48,638	-278 Reduced 0.8%	34,445 $5.28 Billion
Q1 2022 Oct 01, 2025	BUY	$131.98 - $163.75 $1.27 Million - $1.57 Million	9,613 Added 38.28%	34,723 $5.63 Billion
Q4 2021 Oct 02, 2025	SELL	$107.43 - $135.93 $24,923 - $31,535	-232 Reduced 0.66%	34,797 $4.71 Billion
Q3 2021 Oct 02, 2025	BUY	$106.4 - $120.78 $143,640 - $163,053	1,350 Added 4.01%	35,029 $3.78 Billion
Q2 2021 Oct 02, 2025	SELL	$105.21 - $117.21 $21,883 - $24,379	-208 Reduced 0.61%	33,679 $3.79 Billion
Q1 2021 Oct 02, 2025	BUY	$102.3 - $112.62 $897,887 - $988,465	8,777 Added 34.95%	33,887 $3.67 Billion
Q4 2020 Oct 02, 2025	BUY	$80.49 - $108.67 $682,394 - $921,304	8,478 Added 33.76%	33,588 $3.6 Billion
Q3 2020 Oct 02, 2025	SELL	$85.91 - $100.83 $74,226 - $87,117	-864 Reduced 2.55%	33,013 $2.89 Billion
Q2 2020 Oct 02, 2025	BUY	$73.37 - $98.18 $37,492 - $50,169	511 Added 1.53%	33,877 $3.33 Billion
Q1 2020 Oct 02, 2025	BUY	$64.5 - $97.79 $532,512 - $807,354	8,256 Added 32.88%	33,366 $2.54 Billion
Q4 2019 Oct 06, 2025	BUY	$72.13 - $90.25 $769,482 - $962,787	10,668 Added 42.49%	35,778 $3.17 Billion

Others Institutions Holding ABBV

# of Institutions

4,439

Shares Held

1.3B

Call Options Held

15.6M

Put Options Held

11.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $387B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.

Account

Caldwell Trust CO Abb Vie Inc. Transaction History